Why New Drugs And AI Chatbots Won’t Cure Health Care’s Cost Disease Soleil Shah,Suhas Gondi,andNiyum Gandhi June 11, 2026

https://www.healthaffairs.org/content/forefront/why-new-drugs-and-ai-chatbots-won-t-cure-health-care-s-cost-disease?utm_campaign=forefront&utm_medium=email&_hsenc=p2ANqtz--1aLCtwKdTXCjDsNDglDm-1K35fiXhx8bL2twka2O_1LpCb6GktvmC-Lq8DegANxRLhjb1D2M4LZSIAZvkCZjLHnMq1A&_hsmi=423554003&utm_source=hasu The classic cost-disease cure is to “productize” what used to be a service by substituting scalable goods. But in health care, the opportunity lies not in replacing services with goods but in raising productivity across labor-intensive workflows.